Skip to main content
. 2003 Jul;47(7):2088–2092. doi: 10.1128/AAC.47.7.2088-2092.2003

TABLE 1.

Demographic data, underlying illnesses, and vital signs for patients with liver abscess due to K. pneumoniae treated with either cefazolin or an extended-spectrum cephalosporin

Parameter or conditiona No. (%) of patients in:
P
Cefazolin group (n = 59) Extended-spectrum cephalosporin group (n = 48)
Age ≥ 60 yr 31 (52.5) 23 (47.9) 0.63
Females 18 (30.5) 17 (35.4) 0.59
Underlying illnesses
    Diabetes mellitus 35 (59.3) 22 (45.8) 0.16
    Liver cirrhosis 2 (3.4) 2 (4.2) 0.83
    Gall bladder stone 6 (10.2) 7 (14.6) 0.49
    Biliary tract stone 6 (10.2) 7 (14.6) 0.49
    Biliary or GI tract operation 7 (11.9) 4 (8.3) 0.55
    Peptic ulcer 9 (15.3) 5 (10.4) 0.46
    Solid-organ cancer 4 (6.8) 5 (10.4) 0.50
    Alcoholism 5 (8.5) 1 (2.1) 0.15
    Hypertension 11 (18.6) 10 (20.8) 0.78
Vital signs
    BT > 38°C or < 36°C 27 (45.8) 22 (45.8) 0.99
    HR > 90/min 30 (50.8) 22 (45.8) 0.61
    RR > 20/min 21 (35.6) 20 (41.7) 0.52
    MAP < 80 mm Hg 9 (15.3) 11 (22.9) 0.31
APACHE III score > 40 14 (23.7) 14 (29.2) 0.52
a

BT, body temperature; HR, heart rate; RR, respiratory rate; MAP, mean arterial pressure; GI, gastrointestinal. Extended-spectrum cephalosporins were ceftriaxone (n = 25), cefotaxime (n = 10), moxalactam (n = 7), cefoperazone (n = 5), and ceftazidime (n = 1)